Company: PRTA
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001559053-25-000009
Chunk: 156

Company: PROTHENA CORP PUBLIC LTD CO
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 156
---
Right-of-use assets obtained in exchange for lease obligations$217 $3,810 $151 Reclassification of prepaid lease payments to right-of-use assets upon lease commencement$— $7,763 $— At-the market offering costs included in accounts payable and accrued liabilities$— $6 $13 Public offering costs included in accounts payable and accrued liabilities$— $— $220 

See accompanying Notes to Consolidated Financial Statements.

79

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the statement of financial position that sum to the total of the same such amounts shown in the Consolidated Statements of Cash Flows.

Year Ended December 31,202420232022Cash and cash equivalents$471,388 $618,830 $710,406 Restricted cash, current— 1,352 — Restricted cash, non-current860 860 2,212 Total cash, cash equivalents and restricted cash, end of the year$472,248 $621,042 $712,618 

80

Prothena Corporation plc and Subsidiaries

Consolidated Statements of Shareholders' Equity

(in thousands, except share data)

Ordinary SharesAdditionalPaid-inCapitalAccumulatedDeficitTotalShareholders' EquitySharesAmountBalances at December 31, 202146,660,294 $466 $1,181,630 $(716,054)$466,042 Share-based compensation— — 31,322 — 31,322 Issuance of ordinary shares upon exercise of stock options1,282,086 14 17,876 — 17,890 Issuance of ordinary shares in public offering, net of issuance costs of $11.3 million3,250,000 32 172,331 — 172,363 Issuance of ordinary shares under the at-the-market offering program, net of issuance costs of $1.7 million911,228 9 51,365 — 51,374 Net loss— — — (116,949)(116,949)Balances at December 31, 202252,103,608 521 1,454,524 (833,003)622,042 Share-based compensation40,914 40,914 Issuance of ordinary shares upon exercise of stock options1,135,302 12 21,